Doctors’ education: The invisible influence of drug company sponsorship

BMJ

Volumn 336, Issue 7641, 2008, Pages 416-

  Moynihan, Ray ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

TRAMADOL;

AUSTRALIA; DRUG INDUSTRY; GENERAL PRACTITIONER; HEALTH CARE PERSONNEL; HEALTH EDUCATION; MEDICAL EDUCATION; PRIORITY JOURNAL; SHORT SURVEY; ARTICLE; ECONOMICS; FINANCIAL MANAGEMENT;

DRUG INDUSTRY; EDUCATION, MEDICAL; RESEARCH SUPPORT AS TOPIC;

EID: 39749155145     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.39496.430336.DB     Document Type: Article

References (5)

1. HealthEd. HealthEd's educational content. www.healthed.com.au/epages/dynamicwebcsoln.storefront/?ObjectPath=/Shops/HealthED/Categories/about (accessed 15 February 2008).
2. Bowman MA, Pearle DL. Changes in drug prescribing patterns related to commercial company funding of continuing medical education. Journal of Continuing Education in the Health Professions 1988; 8: 13–20.
3. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA 2000; 283: 373–380.
4. Lexchin J. Interactions between physicians and the pharmaceutical industry: what does the literature say? CMAJ 1993; 149: 1401–1407.
5. Brennan TA, Rothman DJ, Blank L, Blumenthal D, Chimonas SC, Cohen JJ, et al. Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA 2006; 295: 429–433.